UK is the First Country to Approve CRISPR Gene Editing for Medical Treatment

Breaking News: UK Approves First Gene Therapy Treatment for Sickle Cell Disease In a medical breakthrough, the United Kingdom’s Medicines and Healthcare Regulatory Agency (MHRA) has approved Casgevy as the first gene therapy treatment for sickle cell disease and thalassemia. This revolutionary treatment developed by Vertex Pharmaceuticals (Europe) Ltd. and CRISPR Therapeutics uses the cutting-edge […]

Continue Reading